← All organizations

MediBeacon

For profitWebsite ↗

Also known as: MediBeacon | MediBeacon, Inc. | MediBeacon, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 31, 2026

Timeline

2010s

Jun 1, 2011
MediBeacon— Founded
Jun 8, 2016
Mannheim Pharma & Diagnostics GmbH— Acquired

Drugs by trial phase (7 distinct, 9 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Mannheim Pharma & Diagnostics GmbH

Recent trials (16)

NCT07080008Lead sponsorPhase 1Jan 31, 2026
NCT07080008OfficialPhase 1Jan 31, 2026
NCT05777174Lead sponsorPhase 3Mar 20, 2023
NCT05943977CollaboratorPhase 3Mar 2, 2023
NCT05425719Lead sponsorPhase 3Jun 14, 2022
NCT05425719Study directorPhase 3Jun 14, 2022
NCT03962998Study directorEarly Phase 1Aug 31, 2019
NCT03962998Lead sponsorEarly Phase 1Aug 31, 2019
NCT04008121Lead sponsorEarly Phase 1Jul 31, 2019
NCT04008121Study directorEarly Phase 1Jul 31, 2019
NCT02772276Lead sponsorPhase 2Jul 1, 2016
NCT02772276Study directorPhase 2Jul 1, 2016
NCT02098187Lead sponsorPhase 1Mar 1, 2014
NCT02098187Study directorPhase 1Mar 1, 2014
NCT02098174Study directorPhase 1Nov 1, 2013

Details

Founded: St Louis, MO, US Jun 1, 2011
Last known activity: Jan 31, 2026